Skip to main content
HeartSciences Inc. logo

HeartSciences Inc. — Investor Relations & Filings

Ticker · HSCS ISIN · US42254E1047 US Professional, scientific and technical activities
Filings indexed 235 across all filing types
Latest filing 2022-07-06 Director's Dealing
Country US United States of America
Listing US HSCS

About HeartSciences Inc.

https://heartsciences.com/

HeartSciences Inc. is a medical technology company that specializes in applying artificial intelligence (AI) and deep learning to electrocardiography (ECG). The company's core focus is on developing proprietary, device-agnostic AI-ECG algorithms to enhance the clinical utility of the standard ECG. By analyzing waveform data, its technology aims to enable earlier and more accurate detection of heart disease and other cardiac conditions that are often missed by traditional interpretation methods. A key application of its research involves creating algorithms to predict specific conditions, such as cardiomyopathy, from ECG signals.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2022-07-06 English
FORM 3 SUBMISSION
Director's Dealing
2022-07-06 English
FORM 3 SUBMISSION
Director's Dealing
2022-07-06 English
FORM 3 SUBMISSION
Director's Dealing
2022-07-06 English
FORM 3 SUBMISSION
Director's Dealing
2022-07-06 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the closing of an IPO, issuance of warrants, amendment to the certificate of formation, and related agreements. It does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). Instead, it reports on capital raising activities and corporate governance amendments. The primary focus is on the IPO and related financing transactions, including warrant issuance and amendments to corporate documents. Therefore, the document fits best under Capital/Financing Update (CAP). The document length (8815 characters) and detailed description of the IPO and related agreements support this classification with high confidence.
2022-06-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.